Press "Enter" to skip to content

Zanubrutinib-Gazyva Shows Promise for CLL/SLL, Follicular Lymphoma – Lymphoma News Today

admin 0

Zanubrutinib-Gazyva Shows Promise for CLL/SLL, Follicular Lymphoma  Lymphoma News Today

Findings of a Phase 1b trial show that zanubrutinib-Gazyva leads to clinically meaningful responses in patients with CLL/SLL and follicular lymphoma.

“lymphoma cancer” – Google News

(Visited 1 times, 1 visits today)

Leave a Reply

Your email address will not be published. Required fields are marked *